Vistagen phase 3 study sees placebo surprise, putting future of social anxiety asset into question: analyst

FierceBiotechKurma closes €215M Europe-focused fund to spread across 20 biotechs

FierceBiotechPfizer cans work on next-gen conjugate in cancer patients

Thermo FisherThermo Fisher (TMO) Q1 2026 Earnings Transcript - The Motley Fool

Lonza NewsBanks kick off talks on Lone Star’s $1.75 billion Lonza unit debt - Bloomberg News - TradingView

Promega BlogThe Body Already Knows

Lonza NewsBanks Kick Off Talks on Lone Star’s €1.5 Billion Lonza Unit Debt - Bloomberg.com

Thermo FisherThermo Fisher Scientific Q1 2026 Earnings Call: Complete Transcript - Benzinga

Thermo FisherThermo Fisher stock drops despite Q1 beat (update) (TMO:NYSE) - Seeking Alpha

BioWorldAvacta Life Sciences patents FAP-activated camptothecin conjugates

BioWorldMabwell discloses new ADAM9-targeting ADCs

BioWorldFosun Pharma discovers new PKMYT1 inhibitors

BioWorldChengdu Mfs Pharma synthesizes new compounds for pain